Expression and immunolocalisation of antimicrobial peptides within human palatine tonsils

Journal of Laryngology and Otology

Volumn 121, Issue 10, 2007, Pages 973-978

  Ball, S L ^a   Siou, G P ^a   Wilson, J A ^a   Howard, A ^a   Hirst, B H ^a   Hall, J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antimicrobial Cationic Peptides; Tonsil; Tonsillitis

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN; HEPCIDIN; PEPTIDE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; RNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; PALATINE TONSIL; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONSILLITIS; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; DISEASE PREDISPOSITION; METABOLISM; METHODOLOGY; RECURRENT DISEASE; TONSIL;

ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOHISTOCHEMISTRY; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TONSIL; TONSILLITIS;

EID: 38449104015     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107006184     Document Type: Article

References (16)

1. Nave H, Gebert A, Pabst R. Morphology and immunology of the human palatine tonsil. Anat Embryol (Berl) 2001; 204:367-73
2. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002;14:96-102
3. Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000;8:402-10
4. Wehkamp J, Fellermann K, Herrlinger KR, Bevins CL, Stange EF. Mechanisms of disease: defensins in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2:406-15
5. Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006;18:24-30
6. Bowdish DM, Davidson DJ, Hancock RE. Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 2006;306:27-66
7. Brook I. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 2001;17:439-42
8. Stenfors LE, Bye HM, Raisanen S. Noticeable differences in bacterial defence on tonsillar surfaces between bacteria-induced and virus-induced acute tonsillitis. Int J Pediatr Otorhinolaryngol 2003;67:1075-82
9. Krause A, Sillard R, Kleemeier B, Kluver E, Maronde E, Conejo-Garcia JR et al. Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Protein Sci 2003;12:143-52
10. Chae SW, Lee SH, Cho JH, Lee HM, Choi G, Hwang SJ. Expression of human beta-defensin 1 mRNA in human palatine tonsil. Acta Otolaryngol 2001;121:414-18
11. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-13
12. Claeys S, de Belder T, Holtappels G, Gevaert P, Verhasselt B, van Cauwenbergr P et al. Human beta-defensins and toll-like receptors in the upper airway. Allergy 2003;58:748-53
13. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA. Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 1998;66:4222-8
14. Meyer JE, Harder J, Gorogh T, Weise JB, Schubert S, Janssen D et al. Human beta-defensin-2 in oral cancer with opportunistic Candida infection. Anticancer Res 2004;24:1025-30
15. Murakami M, Ohtake T, Dorschner RA, Gallo RL. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 2002;81:845-50
16. Song JJ, Hwang KS, Woo JS, Chae SW, Cho JG, Kang HE et al. Expression of cathelicidin in recurrent throat infection. Int J Pediatr Otorhinolaryngol 2006;70:487-92